keyboard_backspaceTerm

Details

  • menuadd_circle_outlineDomain IDclose
  • menuadd_circle_outlineConcept Class IDclose
  • menuadd_circle_outlineVocabulary ID
    help_outline
    close
  • menuadd_circle_outlineConcept IDclose
  • menuadd_circle_outlineConcept codeclose
  • menuadd_circle_outlineValidityclose
  • menuadd_circle_outlineConceptclose
  • menuadd_circle_outlineValid start28-Apr-2025close
  • menuadd_circle_outlineValid end28-Apr-2025close

Term connections

RelationshipRelates toConcept idVocabulary
Contraindicated by (NDF-RT)
Drug Hypersensitivity
4342429
NDFRT
Gallbladder Diseases
4342945
NDFRT
Kidney Failure
4267462
NDFRT
Liver Cirrhosis, Biliary
4265940
NDFRT
Liver Failure
4267336
NDFRT
Has chemical structure (NDF-RT)
PPAR alpha
4317734
NDFRT
Has ingredient (NDF-RT)
Gemfibrozil
4351287
NDFRT
Has mechanism of action (NDF-RT)
Peroxisome Proliferator-activated Receptor alpha Agonists
4317995
NDFRT
Has pharmacokinetics (NDF-RT)
Hepatic Metabolism
4340575
NDFRT
Renal Excretion
4340578
NDFRT
Has physiological effect (NDF-RT)
Increased Lipolysis
4329609
NDFRT
Is a
G
44507396
NDFRT
Peroxisome Proliferator Receptor alpha Agonist
4333662
NDFRT
Is involved in drug-drug interaction (NDF)
ATORVASTATIN CALCIUM/GEMFIBROZIL
4286840
NDFRT
BEXAROTENE/GEMFIBROZIL
4259590
NDFRT
CERIVASTATIN SODIUM/GEMFIBROZIL
4283586
NDFRT
DABRAFENIB/GEMFIBROZIL
43561701
NDFRT
ENZALUTAMIDE/GEMFIBROZIL
43014348
NDFRT
EZETIMIBE/GEMFIBROZIL
4249226
NDFRT
FLUVASTATIN SODIUM/GEMFIBROZIL
4354120
NDFRT
GEMFIBROZIL/LOVASTATIN
4353198
NDFRT
GEMFIBROZIL/PIOGLITAZONE
40236611
NDFRT
GEMFIBROZIL/PIOGLITAZONE HCL
4259598
NDFRT
GEMFIBROZIL/PITAVASTATIN
40227264
NDFRT
GEMFIBROZIL/PRAVASTATIN
4354006
NDFRT
GEMFIBROZIL/REPAGLINIDE
4248485
NDFRT
GEMFIBROZIL/ROSUVASTATIN
4250987
NDFRT
GEMFIBROZIL/SIMVASTATIN
4354007
NDFRT
GEMFIBROZIL/WARFARIN
4286976
NDFRT
May prevent (NDF-RT)
Coronary Artery Disease
4341435
NDFRT
May treat (NDF-RT)
Coronary Artery Disease
4341435
NDFRT
Hypercholesterolemia
4267165
NDFRT
Hyperlipoproteinemias
4266107
NDFRT
Hypertriglyceridemia
4266904
NDFRT
NDF-RT to RxNorm equivalent (RxNorm)
gemfibrozil
1558242
RxNorm
Pharmaceutical Preparation to Chemical Structure equivalent (NDF-RT)
Gemfibrozil
4351287
NDFRT
Product component of (NDF-RT)
GEMFIBROZIL 300MG CAP
42859466
NDFRT
GEMFIBROZIL 600MG TAB
42854147
NDFRT
GEMFIBROZIL 600MG TAB,UD
42854148
NDFRT
Subsumes
GEMFIBROZIL 300MG CAP
42859466
NDFRT
GEMFIBROZIL 600MG TAB
42854147
NDFRT
GEMFIBROZIL 600MG TAB,UD
42854148
NDFRT
close modal

Athena – OHDSI Vocabularies Repository

@ 2015-2025, Odysseus Data Services, Inc. All rights reserved

Version 1.15.4.47.250313.1129

OMOP Vocabulary version: v20250227

Report application issue

Report vocabulary content issues

close modal

License Agreement

In order to use the SNOMED International SNOMED CT Browser and HemOnc, please accept the following license agreement:

SNOMED INTERNATIONAL SNOMED CT LICENSE AGREEMENT

SNOMED International SNOMED CT Browser includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the SNOMED International. All rights reserved. SNOMED CT® was originally created by the College of American Pathologists.
“SNOMED”, “SNOMED CT” and “SNOMED Clinical Terms” are registered trademarks of the SNOMED International (www.snomed.org)

Use of SNOMED CT in SNOMED International SNOMED CT Browser is governed by the conditions of the following SNOMED CT license issued by SNOMED International:
  1. The meaning of the terms “Affiliate”, or “Data Analysis System”, “Data Creation System”, “Derivative”, “End User”, “Extension”, “Member”, “Non-Member Territory”, “SNOMED CT” and “SNOMED CT Content” are as defined in the SNOMED International Affiliate License Agreement (see on the SNOMED International web site).
  2. Information about Affiliate Licensing is available athttp://www.snomed.org/snomed-ct/get-snomed-ct. Individuals or organizations wishing to register as SNOMED International Affiliates can register at mlds.ihtsdotools.org, subject to acceptance of the Affiliate License Agreement (see on the SNOMED International web site).
  3. The current list of SNOMED International Member Territories can be viewed at www.snomed.org/members. Countries not included in that list are "Non-Member Territories".
  4. End Users, that do not hold an SNOMED International Affiliate License, may access SNOMED CT® using SNOMED International SNOMED CT Browser subject to acceptance of and adherence to the following sub-license limitations:
    1. The sub-licensee is only permitted to access SNOMED CT® using this software (or service) for the purpose of exploring and evaluating the terminology.
    2. The sub-licensee is not permitted the use of this software as part of a system that constitutes a SNOMED CT "Data Creation System" or "Data Analysis System", as defined in the SNOMED International Affiliate License. This means that the sub-licensee must not use SNOMED International SNOMED CT Browser to add or copy SNOMED CT identifiers into any type of record system, database or document.
    3. The sub-licensee is not permitted to translate or modify SNOMED CT Content or Derivatives.
    4. The sub-licensee is not permitted to distribute or share SNOMED CT Content or Derivatives.
  5. SNOMED International Affiliates may use SNOMED International SNOMED CT Browser as part of a "Data Creation System" or "Data Analysis System" subject to the following conditions:
    1. The SNOMED International Affiliate, using SNOMED International SNOMED CT Browsermust accept full responsibility for any reporting and fees due for use or deployment of such a system in a Non-Member Territory.
    2. The SNOMED International Affiliate must not useSNOMED International SNOMED CT Browser to access or interact with SNOMED CT in any way that is not permitted by the Affiliate License Agreement.
    3. In the event of termination of the Affiliate License Agreement, the use ofSNOMED International SNOMED CT Browser will be subject to the End User limitations noted in 4.

HemOnc license agreement

The HemOnc Vocabulary is a derivative product of HemOnc.org, which is wholly owned and operated by HemOnc.org LLC. Use of the HemOnc Vocabulary is governed by the conditions of this License Agreement issued by HemOnc.org LLC:
  1. The meaning of the terms “Data Analysis System”, “Data Creation System”, and “License” is defined below.
  2. If you are already holding a HemOnc ontology License, you are subject to the terms and conditions of the License for the version of the HemOnc Vocabulary which was provided to you. If you wish to obtain this version of the HemOnc Vocabulary, you are subject to the following limitations.
  3. If you currently do not hold a HemOnc ontology License, you may access the HemOnc Vocabulary subject to acceptance of and adherence to the following limitations:
    1. You are permitted to access HemOnc using this software for the purpose of exploring and evaluating the terminology.
    2. You are permitted to use HemOnc as part of a system that constitutes a Data Analysis System, as defined below.
    3. You are not permitted the use of HemOnc as part of a system that constitutes a Data Creation System, as defined below. This means that you must not use HemOnc identifiers in any type of system intended for direct or indirect patient care.
    4. If you share the Licensed Material with a third party, attribution of the HemOnc vocabulary must be given to HemOnc.org LLC, with a URI or hyperlink to HemOnc.org provided if reasonably possible. Use of HemOnc by a third party would be limited to a Data Analysis System and a copy of this License Agreement must be supplied to the third party.
    5. You may not use HemOnc as a substitute for formal medical training, substitute it for independent clinical judgment, and construe it as offering medical advice.

If you wish to utilize the vocabulary for purposes other than specified here, contact us by emailing licensing@hemonc.org.

You agree to indemnify and hold HemOnc.org LLC and all parties who have contributed to HemOnc.org and this derivative product harmless from and against all claims, liability, losses, damages, costs, and expenses, including--but not limited to--legal fees

Definitions

Data Analysis System: a computer system that is used to analyze records or other data, but not if that system is also a Data Creation System

Data Creation System: a computer system that is used to create records or other data that is encoded using HemOnc, for the purposes of facilitating patient care

License: the separate CC BY-NC-SA 4.0 license to the full HemOnc ontology